Literature DB >> 23873101

T-cell infiltration and expressions of T lymphocyte co-inhibitory B7-H1 and B7-H4 molecules among colorectal cancer patients in northeast China's Heilongjiang province.

Ming Liang1, Jingyuan Li, Dandan Wang, Shuchen Li, Yi Sun, Tiewei Sun, Jing Zhang, Xiaoning Chen, Qiang Li, Shibo Sun.   

Abstract

Colorectal cancer has an extremely poor prognosis due to its high rate of recurrence and metastasis. The present study aimed to investigate the correlations between the B7-H1 and B7-H4 expressions as well as the clinicopathological characteristics and the prognosis of patients with colorectal cancer. We further inferred from these findings whether T lymphocyte co-inhibitory molecules (B7-H1 and B7-H4) led to a poor prognosis in Heilongjiang patients with colorectal cancer. Survival analysis revealed that the poor prognosis of these patients was unrelated to patient age, tumor size or histological grade, or lymph node metastasis, but was associated with TNM stage, high B7-H1 and B7-H4 expression levels. High B7-H1 and B7-H4 expressions were closely correlated with poor prognosis in patients with colorectal cancer. We speculate that the joint detection of these molecules may clinically apply for diagnosing and predicting poor prognosis of patients with colorectal cancer in northeast China's Heilongjiang province. In addition, intervention of B7-H1 and B7-H4 may be beneficial for enhancement of immunity in these patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23873101     DOI: 10.1007/s13277-013-1006-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  26 in total

1.  Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family.

Authors:  In-Hak Choi; Gefeng Zhu; Gabriel L Sica; Scott E Strome; John C Cheville; Julie S Lau; Yuwen Zhu; Dallas B Flies; Koji Tamada; Lieping Chen
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

2.  Prognostic significance of AEG-1 expression in colorectal carcinoma.

Authors:  Hongtao Song; Cong Li; Rui Li; Jingshu Geng
Journal:  Int J Colorectal Dis       Date:  2010-07-13       Impact factor: 2.571

3.  Activated macrophages containing tumor marker in colon carcinoma: immunohistochemical proof of a concept.

Authors:  T J E Faber; D Japink; M P G Leers; M N Sosef; M F von Meyenfeldt; M Nap
Journal:  Tumour Biol       Date:  2011-12-02

4.  The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.

Authors:  Susana Salceda; Tenny Tang; Muriel Kmet; Andrei Munteanu; Malavika Ghosh; Roberto Macina; Wenhui Liu; Glenn Pilkington; Jackie Papkoff
Journal:  Exp Cell Res       Date:  2005-05-15       Impact factor: 3.905

5.  Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma.

Authors:  Ilona Kryczek; Shuang Wei; Gefeng Zhu; Leann Myers; Peter Mottram; Pui Cheng; Lieping Chen; George Coukos; Weiping Zou
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

Review 6.  BTLA: a new inhibitory receptor with a B7-like ligand.

Authors:  Beatriz M Carreno; Mary Collins
Journal:  Trends Immunol       Date:  2003-10       Impact factor: 16.687

7.  Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma.

Authors:  Svetlana Kondratiev; Edmond Sabo; Evgeny Yakirevich; Ofer Lavie; Murray B Resnick
Journal:  Clin Cancer Res       Date:  2004-07-01       Impact factor: 12.531

8.  B7-h4 expression in a range of breast pathology: correlation with tumor T-cell infiltration.

Authors:  Kimberly C Mugler; Meenakshi Singh; Barbara Tringler; Kathleen C Torkko; Wenhui Liu; Jackie Papkoff; Kenneth R Shroyer
Journal:  Appl Immunohistochem Mol Morphol       Date:  2007-12

9.  Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer.

Authors:  Mario Sznol; Lieping Chen
Journal:  Clin Cancer Res       Date:  2013-03-01       Impact factor: 12.531

10.  B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration.

Authors:  Takashi Miyatake; Barbara Tringler; Wenhui Liu; Shu-Hui Liu; Jackie Papkoff; Takayuki Enomoto; Kathleen C Torkko; Donna L Dehn; Ashanta Swisher; Kenneth R Shroyer
Journal:  Gynecol Oncol       Date:  2007-05-16       Impact factor: 5.482

View more
  23 in total

1.  PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients.

Authors:  Diane Goltz; Heidrun Gevensleben; Jörn Dietrich; Dimo Dietrich
Journal:  Oncoimmunology       Date:  2016-11-10       Impact factor: 8.110

2.  Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis.

Authors:  Ninu Maskey; Kai Li; Min Hu; Zhigao Xu; Chunwei Peng; Fang Yu; Hong Cao; Jiamei Chen; Yan Li; Guifang Yang
Journal:  Tumour Biol       Date:  2014-09-27

3.  Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.

Authors:  Yohei Masugi; Reiko Nishihara; Juhong Yang; Kosuke Mima; Annacarolina da Silva; Yan Shi; Kentaro Inamura; Yin Cao; Mingyang Song; Jonathan A Nowak; Xiaoyun Liao; Katsuhiko Nosho; Andrew T Chan; Marios Giannakis; Adam J Bass; F Stephen Hodi; Gordon J Freeman; Scott Rodig; Charles S Fuchs; Zhi Rong Qian; Shuji Ogino
Journal:  Gut       Date:  2016-05-05       Impact factor: 23.059

4.  A meta-analysis reveals prognostic role of programmed death ligand-1 in Asian patients with non-small cell lung cancer.

Authors:  Xiao-Yan Hu; Wei Zhang; Yue Hu; Yong Zhang; Rui Gong; Jin-Yan Liang; Li Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

5.  Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics.

Authors:  Meng Yang; Yun-Duo Liu; Yan-Ying Wang; Tian-Bo Liu; Ting-Ting Ge; Ge Lou
Journal:  Tumour Biol       Date:  2013-08-27

6.  Role of B7-H4 siRNA in Proliferation, Migration, and Invasion of LOVO Colorectal Carcinoma Cell Line.

Authors:  Hai-Xia Peng; Wei-Qi Wu; Da-Ming Yang; Rong Jing; Ji Li; Feng-Li Zhou; Yun-Fei Jin; Sai-Yu Wang; Yi-Min Chu
Journal:  Biomed Res Int       Date:  2015-05-21       Impact factor: 3.411

7.  Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction.

Authors:  Yun-Peng Peng; Jing-Jing Zhang; Wen-biao Liang; Min Tu; Zi-Peng Lu; Ji-Shu Wei; Kui-Rong Jiang; Wen-Tao Gao; Jun-Li Wu; Ze-Kuan Xu; Yi Miao; Yi Zhu
Journal:  BMC Cancer       Date:  2014-10-02       Impact factor: 4.430

8.  Prognostic significance of programmed cell death 1 (PD-1) or PD-1 ligand 1 (PD-L1) Expression in epithelial-originated cancer: a meta-analysis.

Authors:  Yaxiong Zhang; Shiyang Kang; Jianfei Shen; Jiaxi He; Long Jiang; Wei Wang; Zhihua Guo; Guilin Peng; Gang Chen; Jianxing He; Wenhua Liang
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

9.  The expression status and prognostic significance of programmed cell death 1 ligand 1 in gastrointestinal tract cancer: a systematic review and meta-analysis.

Authors:  Baohua Huang; Lei Chen; Cuixia Bao; Chengming Sun; Jie Li; Lipeng Wang; Xia Zhang
Journal:  Onco Targets Ther       Date:  2015-09-15       Impact factor: 4.147

Review 10.  PD-L1 expression in human cancers and its association with clinical outcomes.

Authors:  Xin Wang; Feifei Teng; Li Kong; Jinming Yu
Journal:  Onco Targets Ther       Date:  2016-08-12       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.